Ausgabe 14/2020
Inhalt (15 Artikel)
Open Access
Current Opinion
Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?
Vanessa Bianconi, Francesco Violi, Francesca Fallarino, Pasquale Pignatelli, Amirhossein Sahebkar, Matteo Pirro
Review Article
Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders
Flavien Bizot, Adeline Vulin, Aurélie Goyenvalle
Correction
Correction to: Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders
Flavien Bizot, Adeline Vulin, Aurélie Goyenvalle
Review Article
Peripheral Enthesitis in Spondyloarthritis: Lessons from Targeted Treatments
Gurjit S. Kaeley, Jaspreet K. Kaler
Open Access
Review Article
The Expanding Role of the COX Inhibitor/Opioid Receptor Agonist Combination in the Management of Pain
Giustino Varrassi, Cheng Teng Yeam, Martina Rekatsina, Joseph V. Pergolizzi, Panagiotis Zis, Antonella Paladini
Adis Drug Evaluation
Daratumumab: A Review in Combination Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma
Yvette N. Lamb
Adis Drug Evaluation
Rivaroxaban: A Review for Secondary CV Prevention in CAD and PAD
Lesley J. Scott
Letter to the Editor
Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
Dimitrios A. Vrachatis, Sotiria G. Giotaki, George Giannopoulos, Spyridon Deftereos, Bernhard Reimers
Letter to the Editor
Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”
John G. Rizk, Kamyar Kalantar-Zadeh, Mandeep R. Mehra, Carl J. Lavie, Youssef Rizk, Donald N. Forthal
Open Access
Correction
Correction to: Risankizumab: A Review in Moderate to Severe Plaque Psoriasis
Hannah A. Blair
Open Access
Correction
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
L. J. Scott